Tin tức & Cập nhật

Can stool test detect GI cancers?

07 Sep 2023 bởi

In a prospective study from China, a novel noninvasive stool DNA methylation assay showed promise for the early detection of multiple gastrointestinal (GI) cancers.

Can stool test detect GI cancers?

07 Sep 2023

HIMALAYA: Long-term OS benefit with STRIDE regimen in uHCC

07 Sep 2023 bởi

Treatment with tremelimumab plus durvalumab (STRIDE* regimen) continues to yield overall survival (OS) benefit at 4 years among patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib, according to the updated results of the HIMALAYA trial presented at ESMO WCGIC 2023.

HIMALAYA: Long-term OS benefit with STRIDE regimen in uHCC

07 Sep 2023

Frailty ups hospitalization cost, death risk in paediatric cancer patients

06 Sep 2023

Frailty is associated with greater treatment cost and mortality among hospitalized children with cancer, suggests a US study, noting the need for further research on frailty-based risk stratification, as well as individualized intervention to improve patient outcomes.

Frailty ups hospitalization cost, death risk in paediatric cancer patients

06 Sep 2023

Recurrence high in low-grade myofibroblastic sarcoma at sinus/skull base

06 Sep 2023

The risk of recurrence is high among patients with low-grade myofibroblastic sarcoma (LGMS) of the paranasal sinuses and skull, reveals a study, noting that close monitoring is necessary.

Recurrence high in low-grade myofibroblastic sarcoma at sinus/skull base

06 Sep 2023

Anti-HER-2/neu vaccine may benefit gastric cancer patients

06 Sep 2023 bởi

In patients with HER-2-overexpressing metastatic or advanced gastric/gastroesophageal (G/GEJ) adenocarcinoma, a regimen comprising standard-of-care chemotherapy and a HER2-targeting peptide vaccine induced antibody responses that corresponded with tumour size reduction, according to an analysis of the HERIZON study which looked into the correlation between antibody responses and clinical outcomes.

Anti-HER-2/neu vaccine may benefit gastric cancer patients

06 Sep 2023

Photobiomodulation works for chemo-induced peripheral neuropathy

06 Sep 2023 bởi

Photobiomodulation helps to reduce the severity of chemotherapy-induced peripheral neuropathy (CIPN) and increases mobility in cancer patients as shown in a study presented at EAN 2023.

Photobiomodulation works for chemo-induced peripheral neuropathy

06 Sep 2023

Is pembrolizumab-lenvatinib effective in recurrent endometrial cancer?

05 Sep 2023

Combination treatment with pembrolizumab and lenvatinib appears to be a better option for patients with recurrent endometrial cancer (REC) or advanced endometrial cancer (AEC) with a platinum-free interval (PFI) of <6 months, suggests a recent study.

Is pembrolizumab-lenvatinib effective in recurrent endometrial cancer?

05 Sep 2023

Blood test holds promise for early cancer detection

05 Sep 2023 bởi

In an interim analysis of the K-DETEK study, a noninvasive blood test was able to detect early-stage cancer and identify tumour location in asymptomatic individuals in Vietnam.

Blood test holds promise for early cancer detection

05 Sep 2023

Pembrolizumab kết hợp gemcitabine/cisplatin cải thiện sống còn ở bệnh nhân ung thư đường mật di căn

05 Sep 2023 bởi

Kết quả của nghiên cứu KEYNOTE-966 cho thấy, điều trị bằng pembrolizumab (pembro) kết hợp với gemcitabine và cisplatin (gem/cis) cải thiện thời gian sống thêm toàn bộ (OS) đáng kể về mặt thống kê và có ý nghĩa lâm sàng khi so sánh với giả dược kết hợp với gem/cis ở những bệnh nhân ung thư đường mật di căn (BTC) hoặc BTC không thể phẫu thuật cắt bỏ chưa được điều trị trước đó.

Pembrolizumab kết hợp gemcitabine/cisplatin cải thiện sống còn ở bệnh nhân ung thư đường mật di căn

05 Sep 2023

Radiotherapy after ESD improves survival of patients with LVI in pT1b ESCC

04 Sep 2023

Adjuvant radiotherapy following endoscopic submucosal dissection (ESD) results in better survival in patients with lymphovascular invasion (LVI) in T1bN0M0 esophageal squamous cell cancer (ESCC), a study has shown.

Radiotherapy after ESD improves survival of patients with LVI in pT1b ESCC

04 Sep 2023

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Can stool test detect GI cancers?

Can stool test detect GI cancers?

HIMALAYA: Long-term OS benefit with STRIDE regimen in uHCC

HIMALAYA: Long-term OS benefit with STRIDE regimen in uHCC

Frailty ups hospitalization cost, death risk in paediatric cancer patients

Frailty ups hospitalization cost, death risk in paediatric cancer patients

Recurrence high in low-grade myofibroblastic sarcoma at sinus/skull base

Recurrence high in low-grade myofibroblastic sarcoma at sinus/skull base

Anti-HER-2/neu vaccine may benefit gastric cancer patients

Anti-HER-2/neu vaccine may benefit gastric cancer patients

Photobiomodulation works for chemo-induced peripheral neuropathy

Photobiomodulation works for chemo-induced peripheral neuropathy

Is pembrolizumab-lenvatinib effective in recurrent endometrial cancer?

Is pembrolizumab-lenvatinib effective in recurrent endometrial cancer?

Blood test holds promise for early cancer detection

Blood test holds promise for early cancer detection

Pembrolizumab kết hợp gemcitabine/cisplatin cải thiện sống còn ở bệnh nhân ung thư đường mật di căn

Pembrolizumab kết hợp gemcitabine/cisplatin cải thiện sống còn ở bệnh nhân ung thư đường mật di căn

Radiotherapy after ESD improves survival of patients with LVI in pT1b ESCC

Radiotherapy after ESD improves survival of patients with LVI in pT1b ESCC